UroGen Pharma reported a gross margin of 90.93% and a net margin of -19.81% for the quarter ended Jun 2026. These financial ratios cover 38 quarters of results from Mar 2017 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Ratios | Mar2017 | Jun2017 | Sep2017 | Dec2017 | Mar2018 | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||||||||||||||||||||||||||||||
| Gross Margin | 89.04% | 90.18% | 88.76% | 88.88% | 87.45% | 87.49% | 86.83% | 88.44% | 88.65% | 90.28% | 90.80% | 89.80% | 90.27% | 89.94% | 88.50% | 85.34% | 88.07% | 91.31% | 91.88% | 90.93% | ||||||||||||||||||
| EBT Margin | -266.15% | -168.88% | -206.92% | -160.56% | -156.07% | -155.76% | -175.62% | -113.92% | -104.97% | -94.19% | -171.62% | -152.71% | -93.56% | -141.92% | -214.53% | -202.04% | -125.18% | -70.40% | -55.63% | -12.04% | ||||||||||||||||||
| EBIT Margin | -206.50% | -123.13% | -161.88% | -112.71% | -112.36% | -112.10% | -128.23% | -72.77% | -64.74% | -62.09% | -137.05% | -118.27% | -69.61% | -112.59% | -182.26% | -171.17% | -99.65% | -50.52% | -39.76% | 0.15% | ||||||||||||||||||
| EBITDA Margin | -206.50% | -123.13% | -161.88% | -112.71% | -112.36% | -112.10% | -128.23% | -72.77% | -64.74% | -62.09% | -137.05% | -118.27% | -69.61% | -112.59% | -182.26% | -171.17% | -99.65% | -50.52% | -39.76% | 0.15% | ||||||||||||||||||
| Operating Margin | -206.50% | -123.13% | -161.88% | -112.71% | -112.36% | -112.10% | -128.23% | -72.77% | -64.74% | -62.09% | -137.05% | -118.27% | -69.61% | -112.59% | -182.26% | -171.17% | -99.65% | -50.52% | -39.76% | 0.15% | ||||||||||||||||||
| Net Margin | -266.15% | -11.43% | -209.32% | -160.75% | -160.47% | -12.53% | -175.74% | -114.18% | -104.93% | 2.21% | -171.91% | -152.89% | -93.93% | -25.04% | -216.47% | -206.24% | -121.34% | 23.79% | -46.26% | -19.81% | ||||||||||||||||||
| FCF Margin | -167.59% | -120.67% | -178.16% | -147.40% | -112.87% | -121.72% | -152.56% | -94.28% | -79.28% | -55.18% | -163.97% | -106.75% | -108.56% | -56.33% | -206.41% | -166.24% | -175.49% | -97.07% | -93.50% | -47.30% | ||||||||||||||||||
| Efficiency | ||||||||||||||||||||||||||||||||||||||
| Inventory AverageInventory Avg. | 3.61M | 4.32M | 4.79M | 4.90M | 4.95M | 4.59M | 4.90M | 5.23M | 5.00M | 5.34M | 6.46M | 7.34M | 7.52M | 8.41M | 8.41M | 7.36M | 7.73M | 12.40M | 18.69M | 22.75M | ||||||||||||||||||
| Assets AverageAssets Avg. | 144.19M | 127.17M | 142.73M | 155.93M | 137.31M | 132.05M | 124.29M | 104.16M | 144.50M | 185.97M | 189.44M | 241.21M | 291.90M | 293.83M | 266.66M | 228.17M | 196.88M | 192.75M | 227.07M | 253.14M | ||||||||||||||||||
| Invested CapitalInvested Cap. | 8.41M | 53.72M | 30.28M | 8.58M | 8.18M | -18.61M | -40.14M | 198.52M | 33.34M | 57.46M | 128.13M | 147.22M | 112.93M | 75.65M | 29.13M | 6.70M | 16.74M | 65.28M | 56.34M | |||||||||||||||||||
| Asset Utilization RatioAsset Util. | 0.28 | 0.38 | 0.38 | 0.37 | 0.45 | 0.49 | 0.55 | 0.70 | 0.53 | 0.44 | 0.45 | 0.35 | 0.31 | 0.31 | 0.34 | 0.41 | 0.49 | 0.57 | 0.62 | 0.75 | ||||||||||||||||||
| Leverage & Solvency | ||||||||||||||||||||||||||||||||||||||
| Debt Ratio | 0.43 | 0.49 | 0.56 | 0.72 | 0.87 | 1.03 | 0.51 | 0.55 | 0.49 | 0.35 | 0.40 | 0.43 | 0.49 | 0.59 | 0.66 | 0.61 | 0.75 | 0.75 | ||||||||||||||||||||
| Valuation | ||||||||||||||||||||||||||||||||||||||
| Price to EarningsP/E | -12.47 | -115.79 | -6.96 | -6.97 | -7.41 | -90.50 | -7.17 | -10.08 | -19.79 | 939.31 | -16.78 | -20.70 | -22.63 | -73.13 | -11.63 | -12.67 | -28.00 | 125.95 | -37.15 | -125.39 | ||||||||||||||||||
| Price to SalesP/S | 33.20 | 13.23 | 14.58 | 11.21 | 11.89 | 11.34 | 12.60 | 11.51 | 20.76 | 20.72 | 28.85 | 31.64 | 21.26 | 18.31 | 25.17 | 26.14 | 33.97 | 29.96 | 17.19 | 24.84 | ||||||||||||||||||
| Price to BookP/B | 11.95 | 25.43 | -11.58 | -4.55 | -3.03 | -2.30 | -1.86 | -1.76 | 4.33 | -7.48 | -13.50 | 22.81 | 21.00 | -51.09 | -10.98 | -6.78 | -8.09 | -10.75 | -7.05 | -13.59 | ||||||||||||||||||
| Enterprise Value | 270.64M | 124.84M | 61.27M | 74.40M | 95.54M | 105.20M | 151.54M | 195.92M | 285.49M | 350.53M | 377.87M | 450.26M | 286.25M | 213.08M | 314.00M | 475.99M | 806.63M | 1,013.07M | 735.50M | 1,691.54M | ||||||||||||||||||
| EV to EBIT | -11.55 | -6.27 | -2.79 | -3.98 | -5.28 | -5.19 | -6.87 | -12.74 | -21.15 | -23.99 | -14.68 | -17.43 | -16.32 | -7.70 | -8.51 | -11.48 | -29.45 | -53.00 | -36.30 | 0.02M | ||||||||||||||||||
| EV to EBITDA | -11.55 | -6.27 | -2.79 | -3.98 | -5.28 | -5.19 | -6.87 | -12.74 | -21.15 | -23.99 | -14.68 | -17.43 | -16.32 | -7.70 | -8.51 | -11.48 | -29.45 | -53.00 | -36.30 | 0.02M | ||||||||||||||||||
| Market Capitalization | 376.85M | 213.98M | 197.72M | 186.14M | 191.45M | 205.16M | 216.59M | 243.23M | 432.91M | 487.50M | 541.92M | 691.34M | 535.82M | 449.77M | 509.89M | 632.94M | 933.66M | 1,133.53M | 875.77M | 1,799.52M | ||||||||||||||||||
| Price to FCFP/FCF | -19.81 | -10.96 | -8.18 | -7.61 | -10.54 | -9.32 | -8.26 | -12.20 | -26.19 | -37.55 | -17.60 | -29.64 | -19.58 | -32.50 | -12.20 | -15.72 | -19.36 | -30.86 | -18.38 | -52.50 | ||||||||||||||||||
| EV to FCF | -14.23 | -6.40 | -2.54 | -3.04 | -5.26 | -4.78 | -5.78 | -9.83 | -17.27 | -27.00 | -12.27 | -19.31 | -10.46 | -15.40 | -7.51 | -11.82 | -16.73 | -27.58 | -15.44 | -49.35 | ||||||||||||||||||
| EV to CFO | -14.65 | -6.22 | -2.55 | -3.07 | -5.42 | -4.84 | -5.87 | -9.66 | -16.50 | -26.97 | -11.91 | -18.96 | -10.35 | -15.65 | -7.47 | -11.95 | -19.08 | -26.43 | -16.23 | -51.25 | ||||||||||||||||||
| Return Ratios | ||||||||||||||||||||||||||||||||||||||
| Return on Sales [ROS]ROS | -206.50% | -123.13% | -161.88% | -112.71% | -112.36% | -112.10% | -128.23% | -72.77% | -64.74% | -62.09% | -137.05% | -118.27% | -69.61% | -112.59% | -182.26% | -171.17% | -99.65% | -50.52% | -39.76% | 0.15% | ||||||||||||||||||
| Return on Capital Employed [ROCE]ROCE | -80.10% | -88.07% | -71.28% | -60.94% | -66.50% | -73.10% | -79.89% | -97.94% | -59.99% | -42.35% | -42.45% | -38.50% | -32.32% | -39.04% | -48.05% | -68.41% | -86.27% | -85.33% | -61.33% | -34.86% | ||||||||||||||||||
| Return on Invested Capital [ROIC]ROIC | -220.51% | -155.30% | -312.66% | -726.27% | 1,170.10% | 197.75% | -67.65% | -43.53% | -118.19% | -68.18% | -48.53% | -57.29% | -90.63% | -193.29% | -613.92% | -820.38% | -186.71% | -69.57% | ||||||||||||||||||||
| Return on Assets [ROA]ROA | -56.00% | -66.22% | -60.72% | -55.89% | -60.28% | -62.99% | -68.39% | -79.16% | -54.32% | -40.71% | -41.06% | -36.09% | -30.44% | -32.51% | -40.15% | -54.17% | -67.70% | -61.29% | -43.10% | -24.60% |